Suppliers / Zhejiang Yongtai Chiral Medicine Technology

Zhejiang Yongtai Chiral Medicine Technology

China Updated 9 July 2026

Zhejiang Yongtai Chiral Medicine Technology is an API manufacturer based in China. It holds 7 active US drug master files and 5 valid CEPs across a filed portfolio of 5 molecules.

7
active US DMFs
5
valid CEPs
3
registered plants 1 with an FDA FEI number
0
filings across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Taizhou, China Not on file
China, China 3019367584
Taizhou City, China Not on file

What they file, and where

Molecule Regulators Docs
Carbidopa EDQM, US FDA 3
Sitagliptin US FDA 3
Gabapentin EDQM, US FDA 2
Levodopa EDQM, US FDA 2
Methyldopa EDQM, US FDA 2

Also appears on these molecule pages

Carbidopa API Gabapentin API Levodopa API Sitagliptin API

Questions about Zhejiang Yongtai Chiral Medicine Technology

Does Zhejiang Yongtai Chiral Medicine Technology hold a US DMF or a CEP?
Zhejiang Yongtai Chiral Medicine Technology holds 7 active US drug master files and 5 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Zhejiang Yongtai Chiral Medicine Technology FDA-registered?
One site operated by Zhejiang Yongtai Chiral Medicine Technology carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Zhejiang Yongtai Chiral Medicine Technology manufacture?
3 registered sites are on record, in China (Taizhou, China and Taizhou City). Every site is listed on this page with the register it came from.
What does Zhejiang Yongtai Chiral Medicine Technology make?
5 molecules are on record against Zhejiang Yongtai Chiral Medicine Technology, including Carbidopa, Sitagliptin, Gabapentin and Levodopa. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Zhejiang Yongtai Chiral Medicine Technology comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Hetero shares 3 molecules Divi's Laboratories shares 3 molecules Maithri Drugs shares 2 molecules Shandong Xinhua Pharmaceutical shares 2 molecules Zhejiang Chiral Medicine Chemicals shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability